>6 months15 mg/kg/dose PO q12h Dose limit: 1 g/day
≥2 years7.5 mg/kg/dose PO q12h
1% to 10%:
Central nervous system: Dizziness (1%)
Dermatologic: Diaper rash (2%), genital pruritus (2%)
Gastrointestinal: Nausea (4%), diarrhea (3%), abdominal pain (1%), vomiting (1%)
Genitourinary: Vaginitis
Hepatic: Increased serum transaminases (2%)
Infection: Superinfection
Evaluate renal function before and during therapy
With prolonged therapy, monitor coagulation tests, CBC, and liver function tests periodically
Monitor for signs of anaphylaxis during first dose
